|
|
Other links at Articles > Business of Medicine |
| 1. |
FDA OKs Concerta for Attention Deficit in Adults
|
|
|
Johnson & Johnson said on Friday U.S. health regulators approved Concerta (methylphenidate) to treat adults with attention deficit hyperactivity disorder, or ADHD. Reuters Health Information
|
| 2. |
Tenet to Sell Broadlane Stake, Proceeds $155 Mln
|
|
|
Hospital operator Tenet Healthcare Corp said on Monday it will sell its interest in health care services company Broadlane Inc to TowerBrook Capital Partners L.P. for proceeds of about $155 million. Reuters Health Information
|
| 3. |
Heparin Contaminant and Mechanism of Adverse Events Published
|
|
|
More details about oversulfated chondroitin sulfate and the mechanism by which it is believed to bring about adverse events have now been published in two separate papers. (Guerrini M et al. Nat Biotechnol; published online before print April 23, 2008. Heartwire
|
| 5. |
Heparin Deaths Higher, FDA Says
|
|
|
As many as 62 deaths over the past 15 months have been linked to tainted heparin on the basis of allergic/hypotensive symptoms, although heparin may not have actually caused the deaths. Heartwire
|
|
|
